ARTICLE | Clinical News
Reclast zoledronic acid regulatory update
June 9, 2008 7:00 AM UTC
FDA approved a label expansion for once-yearly Reclast zoledronic acid to include the prevention of new clinical fractures in patients with a recent low-trauma hip fracture. The company already market...